Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosis.
The Diagnosis and Treatment of Optic Neuritis.
Construction and Characterization of Recombinant HEK Cell Over Expressing α4 Integrin.
Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.
Analysis of tremor in multiple sclerosis using Hilbert-Huang Transform.
The plasticity of human Treg and Th17 cells and its role in autoimmunity.
Central defects of autonomic function in secondary progressive multiple sclerosis: observations based on cardiovascular and growth hormone responses to clonidine.
Regulatory dendritic cell therapy: From rodents to clinical application.
Multiple sclerosis is associated with psoriasis. A case-control study.
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women.
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis.
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.
Exploring Physical Activity in Women with Multiple Sclerosis: Associations with Fear of Falling and Underlying Impairments.
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.
Obturator neurolysis using 65% alcohol for adductor muscle spasticity.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica.
Diagnosing neuromyelitis optica.
Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells.
TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
Pathogenesis of immune-mediated neuropathies.
Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review.
Natalizumab treatment for multiple sclerosis.

Pages